Molecular Oncology
Volume 1, Issue 2 , Pages 196-204 , September 2007

Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer

  • Susan McCarthy

      Affiliations

    • Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida, USA
    • These authors contributed equally to this work.
    • ,
  • Andrea Caporali

      Affiliations

    • Dipartimento di Medicina Sperimentale, Sezione di Biochimica, Università di Parma, Via Volturno 39, 43100 Parma, Italy
    • These authors contributed equally to this work.
    • ,
  • Steve Enkemann

      Affiliations

    • Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida, USA
    • ,
  • Maurizio Scaltriti

      Affiliations

    • Dipartimento di Medicina Sperimentale, Sezione di Biochimica, Università di Parma, Via Volturno 39, 43100 Parma, Italy
    • ,
  • Steve Eschrich

      Affiliations

    • Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida, USA
    • ,
  • Pierpaola Davalli

      Affiliations

    • Department of Scienze Biomediche, University of Modena, Modena, Italy
    • ,
  • Arnaldo Corti

      Affiliations

    • Department of Scienze Biomediche, University of Modena, Modena, Italy
    • ,
  • Alice Lee

      Affiliations

    • Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida, USA
    • ,
  • Jimmy Sung

      Affiliations

    • Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida, USA
    • ,
  • Timothy J. Yeatman

      Affiliations

    • Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida, USA
    • Corresponding Author InformationCorresponding author at: Department of Surgery, H. Lee Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA. Tel.: +1 813 979 7292; fax: +1 813 632 1433.
    • ,
  • Saverio Bettuzzi

      Affiliations

    • Dipartimento di Medicina Sperimentale, Sezione di Biochimica, Università di Parma, Via Volturno 39, 43100 Parma, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 0521 903803; fax: +39 0521 903802.

Received 10 April 2007 ,Revised 29 May 2007 ,Accepted 30 May 2007.

References 

  1. Adhami VM, Ahmad N, Mukhtar H. Molecular targets for green tea in prostate cancer prevention. J. Nutr. 2003;133:S417–S424
  2. Adhami VM, Siddiqui I, Ahmand N, Gupta S, Mukhtar H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-1-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res. 2004;64:8715–8722
  3. Ahmad N, Adhami VM, Gupta S, Cheng P, Mukhtar H. Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate. Arch. Biochem. Biophys. 2002;398:125–131
  4. Blow JJ, Hodgson B. Replication licensing-defining the proliferative state?. Trends Cell Biol. 2002;12(2):72–78
  5. Brawley OW. The potential for prostate cancer chemoprevention. Urology. 2002;4:S11–S17
  6. Caporali A, Davalli P, Astancolle S, D'Arca D, Brausi M, Bettuzzi S, et al. The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression. Carcinogenesis. 2004;25(11):2217–2224
  7. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA. 1997;94:7245–7250
  8. DeGregori J. The Rb network. J. Cell Sci. 2004;117:3411–3413
  9. Doss MX, Potta SP, Hescheler J, Sachinidis A. Trapping of growth factors by catechins: a possible therapeutical target for prevention of proliferative diseases. J. Nutr. Biochem. 2005;16:259–266
  10. Dobbin KK, Beer DG, Meyerson M, Yeatman TJ, Gerald WL, Jacobson JW, et al. Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin. Cancer Res. 2005;11(2Pt1):565–572
  11. Dudderidge TJ, Stoeber K, Loddo M, Atkinson G, Fanshawe T, Griffiths DF, et al. MCM2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin. Cancer Res. 2005;11(7):2510–2517
  12. Gonzalez MA, Pinder SE, Callagy G, Vowler SL, Morris LS, Bird K, et al. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J. Clin. Oncol. 2003;21(23):4306–4313
  13. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, et al. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA. 1995;92:3439–3443
  14. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. USA. 2001;98:10350–10355
  15. Honeycutt KA, Chen Z, Koster MI, Miers M, Nuchtern J, Hicks J, et al. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis. Oncogene. 2006;25(29):4027–4032
  16. Ishida S, Huang E, Zuzan H, Spang R, Leone G, West M, et al. Role of E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol. Cell Biol. 2001;14:4684–4699
  17. Jemal A, Siegal R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics. CA Cancer J. Clin. 2006;56:106–130
  18. Jian L, Xie LP, Lee AH, Binns CW. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int. J. Cancer. 2004;108(1):130–135
  19. Kaplan-Lefko PJ, Chen TM, Ittmann MM, Barrios RJ, Ayala GE, Huss WJ, et al. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate. 2003;55:219–237
  20. Klein EA, Thompson IM. Update on chemoprevention of prostate cancer. Curr. Opin. Urol. 2004;14(3):143–149
  21. Kumar N, Shibata D, Helm J, Coppola D, Malafa M. Green tea polyphenols in the prevention of colon cancer. Front. Biosci. 2007;12:2309–2315
  22. Labib K, Diffley JF. Is the MCM2-7 complex the eukaryotic DNA replication fork replicase?. Curr. Opin. Genet. Dev. 2001;1:64–70
  23. Lei M. The MCM7 complex: its role in DNA replication and implications for cancer therapy. Curr. Cancer Drug Targets. 2005;5:365–380
  24. Luo JH, Yu YP, Cieply K, Lin F, Deflavia P, Dhir R, et al. Gene expression analysis of prostate cancers. Mol. Carcinogen. 2002;33:25–35
  25. Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 2007;15:267–285
  26. Ohtani K, Iwanaga R, Nakamura M, Ikeda M, Yabuta N, Tsuruga H, et al. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F. Oncogene. 1999;18:2299–2309
  27. Padmanabhan V, Callas P, Philips G, Trainer TD, Beatty BG. DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer. J. Clin. Pathol. 2004;57:1057–1062
  28. Ren B, Yu G, Tseng GC, Cieply K, Gavel T, Nelson J, et al. MCM7 amplification and overexpression are associated with prostate cancer progression. Oncogene. 2006;25:1090–1098
  29. Saleem M, Adhami VM, Siddiqui IA, Mukhtar H. Tea beverage in chemoprevention of prostate cancer: a mini-review. Nutr. Cancer. 2003;47:13–23
  30. Saleem M, Adhami VM, Ahmand N, Gupta S, Mukhtar H. Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model. Clin. Cancer Res. 2005;11:147–153
  31. Satariano WA, Ragland KE, Van Den Eden SK. Cause of death in men diagnosed with prostate carcinoma. Cancer. 1998;83(6):1180–1188
  32. Schrader C, Janssen D, Klapper W, Siebmann JU, Meusers P, Brittinger G, et al. Minichromosome maintenance protein 6, a proliferain marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma. Br. J. Cancer. 2005;93:939–945
  33. Siddiqui IA, Adhami VM, Saleem M, Mukhtar H. Beneficial effects of tea and its polyphenols against prostate cancer. Mol. Nutr. Food Res. 2006;50:130–143
  34. Sim HG, Cheng CW. Changing demography of prostate cancer in Asia. Eur. J. Cancer. 2005;41(6):834–845
  35. Stoeber K, Tisty TD, Happerfield L, Thomas GA, Romanov S, Bobrow L, et al. DNA replication licensing and human cell proliferation. J. Cell Sci. 2001;114:2027–2041
  36. Stuart EC, Scandyln MJ, Rosengren RJ. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci. 2006;79(25):2329–2336
  37. Suzuki S, Adachi A, Hiraiwa A, Ohashi M, Ishibashi M, Kiyono T. Cloning and characterization of human MCM7 promoter. Gene. 1998;216(1):85–91
  38. Yang J, Ramnath N, Moysich KB, Asch HL, Swede H, Alrawi SJ, et al. Prognostic significance of MCM2, Ki-67 and gesolin in non-small cell lung cancer. BMC Cancer. 2006;6(203):1–10

PII: S1574-7891(07)00039-7

doi: 10.1016/j.molonc.2007.05.007

Molecular Oncology
Volume 1, Issue 2 , Pages 196-204 , September 2007

Article Tools

* Image Usage & Resolution